HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 1, 2011, Pages 42-46

  Shi, Yi Wu ^a   Min, Fu Li ^a   Liu, Xiao Rong ^a   Zan, Li Xuan ^a   Gao, Mei Mei ^a   Yu, Mei Juan ^a   Liao, Wei Ping ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HLA B ANTIGEN; LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; EPIDERMOLYSIS; EPILEPSY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MACULOPAPULAR RASH; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SAMPLE SIZE; SCHOOL CHILD; STEVENS JOHNSON SYNDROME;

ADOLESCENT; AGED; ALLELES; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHINA; DNA PRIMERS; DRUG ERUPTIONS; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-B ANTIGENS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TRIAZINES; YOUNG ADULT;

EID: 79958827794     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00681.x     Document Type: Article

References (22)

1. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007;48:1223-44.
2. Krivoy N, Taer M, Neuman MG. Antiepileptic drug-induced hypersensitivity syndrome reactions. Curr Drug Saf 2006;1:289-99.
3. Gogtay NJ, Bavdekar SB, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: a review. Expert Opin Drug Saf 2005;4:571-81.
4. *1502 allele in Thai population. Epilepsia 2008;49:2087-91.
5. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
6. Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 2006;7:813-8.
7. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008;9:1617-22.
8. Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008;18:99-107.
9. *5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005;102:4134-9.
10. *1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007;48:1015-8.
11. Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010;11:349-56.
12. Kazeem GR, Cox C, Aponte J, Messenheimer J, Brazell C, Nelsen AC et al. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenet Genomics 2009;19:661-5.
13. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006;16:297-306.
14. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermalnecrolysis: a clinical classification. J Invest Dermatol 1994;102:28S-30S.
15. Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, Erlich H et al. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue Antigens 2007;70:455-63.
16. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
17. Jewell NP. On the bias of commonly used measures of association for 2×2 tables. Biometrics 1986;42:351-8.
18. Lee MT, Hung SI, Wei CY, Chen YT. Pharmacogenetics of toxic epidermal necrolysis. Expert Opin Pharmacother 2010;11:2153-62.
19. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9.
20. Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007;48:1360-5.
21. Messenheimer J, Mullens EL, Giorgi L, Young F. Safety review of adult clinical trial experience with lamotrigine. Drug Saf 1998;18:281-96.
22. Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M et al. Predictors of Lamotrigine-associated rash. Epilepsia 2006;47:318-22.